These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38104117)

  • 1. Loss of two-pore channel 2 function in melanoma-derived tumours reduces tumour growth in vivo but greatly increases tumour-related toxicity in the organism.
    Hanbashi A; Alotaibi M; Sobeai HMA; Binobaid L; Alhazzani K; Jin X; Kamli F; Alhoshani A; Parrington J
    Cancer Cell Int; 2023 Dec; 23(1):325. PubMed ID: 38104117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Two-Pore Channel 2 (TPC2) Expression Increases the Metastatic Traits of Melanoma Cells by a Mechanism Involving the Hippo Signalling Pathway and Store-Operated Calcium Entry.
    D'Amore A; Hanbashi AA; Di Agostino S; Palombi F; Sacconi A; Voruganti A; Taggi M; Canipari R; Blandino G; Parrington J; Filippini A
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32846966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endolysosomal two-pore channel 2 plays opposing roles in primary and metastatic malignant melanoma cells.
    Barbonari S; D'Amore A; Hanbashi AA; Palombi F; Riccioli A; Parrington J; Filippini A
    Cell Biol Int; 2024 Apr; 48(4):521-540. PubMed ID: 38263578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flavonoids increase melanin production and reduce proliferation, migration and invasion of melanoma cells by blocking endolysosomal/melanosomal TPC2.
    Netcharoensirisuk P; Abrahamian C; Tang R; Chen CC; Rosato AS; Beyers W; Chao YK; Filippini A; Di Pietro S; Bartel K; Biel M; Vollmar AM; Umehara K; De-Eknamkul W; Grimm C
    Sci Rep; 2021 Apr; 11(1):8515. PubMed ID: 33875769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene editing and synthetically accessible inhibitors reveal role for TPC2 in HCC cell proliferation and tumor growth.
    Müller M; Gerndt S; Chao YK; Zisis T; Nguyen ONP; Gerwien A; Urban N; Müller C; Gegenfurtner FA; Geisslinger F; Ortler C; Chen CC; Zahler S; Biel M; Schaefer M; Grimm C; Bracher F; Vollmar AM; Bartel K
    Cell Chem Biol; 2021 Aug; 28(8):1119-1131.e27. PubMed ID: 33626324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting TPC2 sensitizes acute lymphoblastic leukemia cells to chemotherapeutics by impairing lysosomal function.
    Geisslinger F; Müller M; Chao YK; Grimm C; Vollmar AM; Bartel K
    Cell Death Dis; 2022 Aug; 13(8):668. PubMed ID: 35915060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TPC2 controls pigmentation by regulating melanosome pH and size.
    Ambrosio AL; Boyle JA; Aradi AE; Christian KA; Di Pietro SM
    Proc Natl Acad Sci U S A; 2016 May; 113(20):5622-7. PubMed ID: 27140606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of [
    Vermeulen K; Naus E; Ahamed M; Attili B; Siemons M; Luyten K; Celen S; Schymkowitz J; Rousseau F; Bormans G
    Theranostics; 2019; 9(2):554-572. PubMed ID: 30809293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.
    García-Hernández ML; Hernández-Pando R; Gariglio P; Berumen J
    Immunology; 2002 Feb; 105(2):231-43. PubMed ID: 11872099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two pore channel 2 (TPC2) inhibits autophagosomal-lysosomal fusion by alkalinizing lysosomal pH.
    Lu Y; Hao BX; Graeff R; Wong CW; Wu WT; Yue J
    J Biol Chem; 2013 Aug; 288(33):24247-63. PubMed ID: 23836916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTORC1 controls lysosomal Ca
    Ogunbayo OA; Duan J; Xiong J; Wang Q; Feng X; Ma J; Zhu MX; Evans AM
    Sci Signal; 2018 Apr; 11(525):. PubMed ID: 29636391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prometastatic Effect of ATX Derived from Alveolar Type II Pneumocytes and B16-F10 Melanoma Cells.
    Dacheux MA; Lee SC; Shin Y; Norman DD; Lin KH; E S; Yue J; Benyó Z; Tigyi GJ
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human genome diversity data reveal that L564P is the predominant TPC2 variant and a prerequisite for the blond hair associated M484L gain-of-function effect.
    Böck J; Krogsaeter E; Passon M; Chao YK; Sharma S; Grallert H; Peters A; Grimm C
    PLoS Genet; 2021 Jan; 17(1):e1009236. PubMed ID: 33465068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca
    Kelu JJ; Webb SE; Parrington J; Galione A; Miller AL
    Dev Biol; 2017 May; 425(2):109-129. PubMed ID: 28390800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The two pore channel TPC2 is dispensable in pancreatic β-cells for normal Ca²⁺ dynamics and insulin secretion.
    Cane MC; Parrington J; Rorsman P; Galione A; Rutter GA
    Cell Calcium; 2016 Jan; 59(1):32-40. PubMed ID: 26769314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endolysosomal Ca
    Alharbi AF; Parrington J
    Front Cell Dev Biol; 2019; 7():302. PubMed ID: 31867325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two pore channel 2 differentially modulates neural differentiation of mouse embryonic stem cells.
    Zhang ZH; Lu YY; Yue J
    PLoS One; 2013; 8(6):e66077. PubMed ID: 23776607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of lysosomal two-pore channel 2 (TPC2) confers neuroprotection in stroke via autophagy regulation.
    Tedeschi V; Vinciguerra A; Sisalli MJ; Pignataro G; Secondo A
    Neurobiol Dis; 2023 Mar; 178():106020. PubMed ID: 36708960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.
    Girard E; Strathdee C; Trueblood E; Quéva C
    Br J Cancer; 2012 Oct; 107(9):1498-505. PubMed ID: 22955855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
    Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
    NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.